Oklahoma 2022 Regular Session

Oklahoma House Bill HB4052 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	SENATE FLOOR VERSION - HB4052 SFLR Page 1
4		-	(Bold face denotes Committee Amendments) 1
	3	+	ENGR. H. B. NO. 4052 Page 1 1
5	4		2
6	5		3
7	6		4
8	7		5
9	8		6
10	9		7
11	10		8
12	11		9
13	12		10
14	13		11
15	14		12
16	15		13
17	16		14
18	17		15
19	18		16
20	19		17
21	20		18
22	21		19
23	22		20
24	23		21
25	24		22
26	25		23
27	26		24
28	27
29		-	SENATE FLOOR VERSION
30		-	April 11, 2022
31		-	AS AMENDED
32		-
33	28		ENGROSSED HOUSE
34	29		BILL NO. 4052 By: Marti and Davis of the
35	30		House
36	31
37	32		and
38	33
39	34		Garvin of the Senate
40	35
41	36
42	37
43	38
44	39
45	40		[ pharmacies - creating certain requi rements ]
46	41
47	42
48	43
	44	+
49	45		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLA HOMA:
50	46		SECTION 1. NEW LAW A ne w section of law to be codified
51	47		in the Oklahoma Statutes as Sectio n 6969 of Title 36, unless there
52	48		is created a duplication in numbering, reads as follows:
53	49		A. As used in this section:
54	50		1. "Pharmacy benefit managers" means individuals or companies
55	51		that manage prescription drug benefits on behalf of health insurers,
56	52		Medicare Part D drug plans, large employer plans, and other payers;
57	53		and
58	54		2. "White bagged drugs" means the distribution of
59	55		patient‐specific medication from a pharmacy, typically a specialty
60	56		pharmacy, to the physician 's office, hospital, or clinic for
61	57		administration.
	58	+	B. All pharmaceutical drug plans and pharmacy benefit managers
	59	+	in this state shall not refuse to authorize, approve , or pay a
62	60
63		-	SENATE FLOOR VERSION - HB4052 SFLR Page 2
64		-	(Bold face denotes Committee Amendments) 1
	61	+	ENGR. H. B. NO. 4052 Page 2 1
65	62		2
66	63		3
67	64		4
68	65		5
69	66		6
70	67		7
71	68		8
72	69		9
73	70		10
74	71		11
75	72		12
76	73		13
77	74		14
78	75		15
79	76		16
80	77		17
81	78		18
82	79		19
83	80		20
84	81		21
85	82		22
86	83		23
87	84		24
88	85
89		-	B. All pharmaceutical drug plans and pharmacy benefit managers
90		-	in this state shall not refuse to authorize, approve , or pay a
91	86		participating provider for providing covered physician -administered
92	87		drugs to covered persons.
93	88		C. All white bagged drugs shall meet supply chain security
94	89		controls set forth by the federal Drug Supply Chain and Security
95	90		Act.
96	91		D. Plan providers shall not require a patient to self-
97	92		administer an injectable drug agai nst a provider's recommendation.
98	93		E. Plans shall not require patients to pay additional fees
99	94		beyond cost-sharing obligations as outlined in the individual's
100	95		plan.
101	96		F. Patients and providers s hall determine a billing pathway
102	97		based on patient's best interest.
103	98		G. Any payer in violation of this section shall be fined a
104	99		minimum of Five Thousand Dollars ($5,000.00) per violation, but not
105	100		more than Ten Thousand Dollars ($10,000.00) per violation. Fines
106	101		related to this section shall not be used when calculating p ayers,
107	102		plans, or members los s ratios and losses shall not be passed on to
108	103		the consumer in future rate increases.
109	104		H. A health care facility or health care provider shall be
110	105		immune from civil liability for any loss or harm to a person due to
111	106		their health insurance plan utilizing white bagged drugs caused by
112	107		an act or omission by the facility or provider that occurs during
	108	+	the process outlined in this act if the act or omission was not the
	109	+	result of gross negligence or willful or wanton misconduct of the
113	110
114		-	SENATE FLOOR VERSION - HB4052 SFLR Page 3
115		-	(Bold face denotes Committee Amendments) 1
	111	+	ENGR. H. B. NO. 4052 Page 3 1
116	112		2
117	113		3
118	114		4
119	115		5
120	116		6
121	117		7
122	118		8
123	119		9
124	120		10
125	121		11
126	122		12
127	123		13
128	124		14
129	125		15
130	126		16
131	127		17
132	128		18
133	129		19
134	130		20
135	131		21
136	132		22
137	133		23
138	134		24
139	135
140		-	the process outlined in this act if the act or omission was not the
141		-	result of gross negligence or willful or wanton misconduct of the
142	136		health care facility of health care provider rendering the health
143	137		care services.
144		-	COMMITTEE REPORT BY: COMMITTEE ON RETIREMENT AND INSURANCE
145		-	April 11, 2022 - DO PASS AS AMENDED
	138	+	Passed the House of Representatives the 22nd day of March, 2022.
	139	+
	140	+
	141	+
	142	+
	143	+	Presiding Officer of the House
	144	+	of Representatives
	145	+
	146	+
	147	+	Passed the Senate the ___ day of __________, 2022.
	148	+
	149	+
	150	+
	151	+
	152	+	Presiding Officer of the Senate
	153	+
	154	+